Ventricular septal defect

Current Treatment Options in Cardiovascular Medicine

Volumn 1, Issue 4, 1999, Pages 311-322

  King, Mary Etta ^a   de Moor, Michael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Congenital Heart Disease; Pulmonary Vascular Resistance; Respiratory Syncytial Virus; Ventricular Septal Defect

Indexed keywords

EID: 0004389237     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-999-0026-4     Document Type: Article

References (43)

1. US Department of Health and Human Services: Ventricular septal defect. MMWR Morb Mortal Wkly Rep 1981, 30:609–610.
2. Gumbiner CH, Takao A: Ventricular septal defect. In The Science and Practice of Pediatric Cardiology, edn 2. Edited by Garson A, Bricker JT, Fisher DJ, Neish SR. Baltimore: Williams & Wilkins; 1998. An excellent, comprehensive, and up-to-date summary of the diagnosis and management of ventricular septal defect.
3. King ME: Echocardiographic evaluation of the adult with unoperated congenital heart disease. In The Practice of Clinical Echocardiography. Edited by Otto CM. Philadelphia: W.B. Saunders Co.; 1997.
4. Kardon RE, Cao QL, Masani N, et al.: New insights and observations in three-dimensional echocardiographic visualization of ventricular septal defects: experimental and clinical studies. Circulation 1998, 98:1307–1314.
5. Magee AG, Boutin C, McCrindle BW, Smallhorn JF: Echocardiography and cardiac catheterization in the preoperative assessment of ventricular septal defect infancy. Am Heart J 1998, 135:907–913.
6. Mitchell SC, Korones SB, Berendes HW: Congenital heart disease in 56,109 births. Circulation 1971, 43:323–332.
7. Moe DG, Guntheroth WG: Spontaneous closure of uncomplicated ventricular septal defect. Am J Cardiol 1987, 60:674–678.
8. Neumayer U, Stone S, Somerville J: Small ventricular septal defects in adults. Eur Heart J 1998, 19:1573–1583. A long-term follow-up of adults with small ventricular septal defects that examines the consequences of long-standing shunt flow.
9. Gersony WM, Hayes CJ, Driscoll DJ, et al.: Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993, 87(suppl I):I121-I126. This entire supplement reports the results of the second natural history study of children with aortic and pulmonic stenosis and ventricular septal defect. It includes data on natural history, echocardiography, exercise performance, recurrence rates, and endocarditis risk.
10. Driscoll D, Allen HD, Atkins DL, et al.: Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. Circulation 1994, 90:2180–2188. This is a statement from the American Heart Association Committee on Congenital Cardiac Defects with evaluation and management algorithms for children with uncomplicated small ventricular septal defects.
11. Schmidt KG, Cassidy SC, Silverman NH, Stargen P: Doubly committed subarterial ventricular septal defects: echocardiographic features and surgical implications. J Am Coll Cardiol 1988, 12:1538–1546.
12. Weidman WH, Blount SG, Dushane JQ, et al.: Clinical course in ventricular septal defect. Circulation 1977, 56(suppl I):I56-I59.
13. Yeager SB, Freed MD, Keane JF, et al.: Primary surgical closure of ventricular septal defect in the first year of life: results in 128 infants. J Am Coll Cardiol 1984, 3:1269–1276.
14. Chang AC, Hanley FL, Lock JE, et al.: Management and outcome of low birth weight neonates with congenital heart disease. J Pediatrics 1994, 3:461–466.
15. Kirklin JW, Appelbaum A, Bargeron LM Jr.: Primary repair versus banding for ventricular septal defects in infants. In The Child with Congenital Heart Disease after Surgery. Edited by Langford-Kidd BS, Rowe RD. Mount Kisco, NY: Futura; 1976.
16. Bridges ND, Perry SB, Keane JF, et al.: Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med 1991, 19:1312–1317.
17. Fishberger SB, Bridges ND, Keane JF, et al.: Intraoperative device closure of ventricular septal defects. Circulation 1993, 88(suppl II):II205-II209.
18. Lock JE, Einzig S, Bass JL, Moller JH: The pulmonary vascular response to oxygen and its influence on operative results in children with ventricular septal defect. Pediatr Cardiol 1982, 3:41–46.
19. Roberts JD, Lang P, Bigatello LM, et al.: Inhaled nitric oxide in congenital heart disease. Circulation 1993, 87:447–453.
20. Yahav J, Avigad S, Frand M, et al.: Assessment of intestinal and cardiorespiratory function in children with congenital heart disease on high-caloric formulas. J Pediatr Gastroenterol Nutr 1985, 4:778–785.
21. Talner NS: Heart failure. In Moss’ Heart Disease in Infants, Children, and Adolescents, edn 4. Edited by Adams FH, Emmanouilides GC, Riemenschneider TA. Baltimore: Williams & Wilkins; 1989.
22. Dajani AS, Taubert KA, Wilson W, et al.: Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997, 277:1794–1801. The most updated American Heart Association guidelines for bacterial endocarditis prophylaxis.
23. Sluysmans T, Stryns-Cailtus M, Tremourous-Wattiez M, et al.: Intravenous enalapril and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy. Am J Cardiol 1989, 70:959–962.
24. Kimball TR, Daniels SR, Meyer RA, et al.: Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect. Am J Cardiol 1991, 13:1377–1382.
25. Boerth RC: Decreased sensitivity of newborn myocardium to the positive inotropic effects of ouabain. In Basic and Therapeutic Aspects of Perinatal Pharmacology. Edited by Morselli PL, Garattini S, Sereni F. New York: Raven Press; 1975.
26. Berner M, Beghetti M, Spahr-Schopferl, et al.: Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with longstanding pulmonary hypertension and congenital heart disease. Am J Cardiol 1996, 77:532–535.
27. Kirklin JW, Appelbaum A, Bargeron LM: Primary repair versus banding for ventricular septal defects in infants. In The Child with Congenital Heart Disease after Surgery. Edited by Langford-Kidd BS, Rowe RD. Mount Kisco, NY: Futura; 1976:3–9.
28. Castaneda AR, Jonas RA, Mayer JE, Hanley FL: Ventricular septal defect. In Cardiac Surgery of the Neonate and Infant. Edited by Castaneda AR, Jonas RA, Mayer JE, Hanley FL. Philadelphia: W.B. Saunders Co.; 1994:187–201. A thorough textbook discussion of the surgical management of ventricular septal defect.
29. Reddy VM, McElhinney DB, Sagrado T, et al.: Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams. J Thorac Cardiovasc Surg 1999:117(2):324–331.
30. Miller O, Celermajer DS, Deanfield JE: Very low dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994, 108(3):487–494.
31. Graham TP Jr., Bricker JT, James FW, Strong WB: 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease. J Am Coll Cardiol 1994, 24:867–873. An excellent consensus conference report cosponsored by the American College of Cardiology and the American College of Sports Medicine. It reviews the recommendations for participation in sports activities by patients with cardiovascular abnormalities. The report of Task Force 1 discusses specific issues related to congenital heart disease.
32. Mahoney LT, Truesdell SC, Hamburgen M, Skorton DJ: Insurability, employability and psychosocial considerations. In Congenital Heart Disease in Adults. Edited by Perloff JK, Child JS. Philadelphia: W.B. Saunders Co.; 1991.
33. Perloff JK: Congenital heart disease and pregnancy. In Principles of Medical Therapy in Pregnancy. Edited by Gleicher N. New York: Plenum Medical Books; 1985:665–671.
34. Canobbio MM: Counseling the adult with congenital heart disease. In Adult Congenital Heart Disease. Edited by Roberts WC. Philadelphia: F.A. Davis Co.; 1987:733–739.
35. Nora JJ, Nora AH: Maternal transmission of congenital heart disease: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol 1987, 59:459–463.
36. Driscoll DJ, Michels VV, Gersony WM, et al.: Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993, 87(suppl I):I114-I120.
37. Ivy DD, Kinsella JP, Ziegler JW, et al.: Dipyridamole attenuated rebound pulmonary hypertension after inhaled nitric oxide withdrawal in post operative congenital heart disease. J Thorac Cardiovasc Surg 1998, 115(4):875–882.
38. Del Nido P: Personal communication.
39. MacDonald NE, Hall CB, Suffin SC, et al.: Respiratory syncytial virus infection in infants with congenital heart disease. N Engl J Med 1982, 307:397–400.
40. American Academy of Pediatrics Committee on Infectious Diseases and Committee of the Fetus and Newborn: Prevention of respiratory syncytial virus: indications for the use of palivizumab and an update on the use of RSV-IGIV. Pediatrics 1998, 102:1211–1216.
41. Sideris E, Walsh KP, Haddad J, et al.: Occlusion of congenital ventricular septal defects by the button device. Heart 1997, 77(3):276–279.
42. Vogel M, Rigby ML, Shore D: Perforation of the right aortic cusp: complication of septal defect closure with a modified Rashkind umbrella. Pediatr Cardiol 1996, 17(6):416–418.
43. Ling PJ, Chang CH, Chu JJ, et al.: Minimally invasive cardiac surgical techniques in the closure of ventricular septal defect: an alternative approach. Ann Thorac Surg 1998, 65:165–170.